Auriculotherapy for Pre-Operative Anxiety
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to use the validated PROMIS Emotional Distress - Anxiety - Short Form 8a and PROMIS Emotional Distress-Depression-Short Form pre-and post-intervention to establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxiety. Subject population will include those having a partial or total nephrectomy for cancer. Drawing the role that auriculotherapy may play in reducing perioperative anxiety related requirement after surgery may also help in reducing the risk of opioid use disorders (OUD) since anxiety has been found to be a major risk factor for OUD in surgical patients. Therefore, this trial will also examine the effect of the auriculotherapy intervention in reducing opioid requirement after surgery.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for pre-operative anxiety?
Is auriculotherapy generally safe for humans?
How does auriculotherapy differ from other treatments for pre-operative anxiety?
Auriculotherapy is unique because it involves stimulating specific points on the ear, which may activate the parasympathetic nervous system to reduce anxiety. Unlike traditional medications, it uses a cryopuncture device with or without nitrogen gas, offering a non-invasive alternative that doesn't rely on drugs.14589
Research Team
Jacques E Chelly, MD
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for adults over 18 who are feeling anxious (with specific anxiety scores) and are about to have kidney cancer surgery. They must understand and agree to the study's process. People with fibromyalgia, ear problems, poor blood flow in the ears, Raynaud's disease, opioid addiction or those needing daily opioids for chronic pain can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative Assessment
Participants complete PROMIS Emotional Distress and Pain Catastrophizing Scale questionnaires to assess eligibility and baseline anxiety and depression levels
Treatment
Auriculotherapy treatment with or without nitrogen gas is administered in the pre-operative setting
Post-operative Monitoring
Participants are assessed for pain medication requirement and pain scores in the post-anesthesia care unit (PACU) and daily until discharge
Follow-up
Participants are monitored for emotional distress, pain, and opioid consumption through questionnaires and phone calls
Treatment Details
Interventions
- Auriculotherapy cryopuncture device with nitrogen gas
- Auriculotherapy cryopuncture device without nitrogen gas
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jacques E. Chelly
Lead Sponsor